Orchid Pharma Limited has informed the Exchange about Schedule of meet
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Orchid Pharma has informed exchanges about an upcoming Analysts/Investors Earnings Call scheduled for Tuesday, August 12, 2025 at 4:30 PM (IST). The call, hosted by Systematix Institutional Equities, will discuss the company's financial performance and results for Q1 FY2025-26 (quarter ended June 30, 2025). Management will be represented by Managing Director Manish Dhanuka, Whole Time Director Mridul Dhanuka, and CFO Sunil Kumar Gupta. This is a continuation of the company's earlier intimation dated August 05, 2025 regarding the Board Meeting schedule. Investors can join via toll-free numbers for India, USA, UK, Singapore, and Hong Kong, or use the Diamond Pass for direct access.
This is a routine regulatory disclosure ahead of the Q1 FY26 earnings call. No immediate price-moving impact is expected, but investors should watch for management commentary on financial performance during the call on August 12, 2025.